Prof Henry Prince
Honorary (Professorial Fellow)
Department of Medicine
897 Scholarly works
11 Projects
HIGHLIGHTS
2026
Journal article
Occupational exposure to radiofrequency electromagnetic fields and risk of follicular lymphoma: Family case-control study
DOI: 10.1016/j.canep.2026.1032332026
Journal article
Early-Life Exposures and Risk of Multiple Myeloma: A Population-Based Case–Control Study in Australia
DOI: 10.1002/ijc.705392026
Journal article
Author reply.
DOI: 10.1111/imj.706412026
Journal article
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study
DOI: 10.1016/j.tranon.2026.1028712023
Research grants (ARC, NHMRC, MRFF)
Novel Approaches to the Treatment and Monitoring of Patients With Incurable Haematological Cancers
2018
Research Grant
Immunobiology and Immunotherapy of Cancer
2009
Journal article
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure
DOI: 10.1200/JCO.2008.18.8573
RECENT SCHOLARLY WORKS
2026
Journal article
A Case of Primary Cutaneous BRAFV600E Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNA
DOI: 10.1111/ajd.701432026
Journal article
POSTER: TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas
DOI: 10.1016/s2152-2650(26)01255-32026
Journal article
TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas
DOI: 10.1016/s2152-2650(26)02792-82026
Journal article
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease
DOI: 10.1111/imj.704602026
Journal article
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma
DOI: 10.1182/blood.20250301902026
Journal article
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
DOI: 10.1111/imj.70329
RECENT PROJECTS
2014
Research Grant
Victorian Epigenetics Group (Veg): A Collaboration for Personalised Epigenetic Cancer Therapy Through Pre-Clinical Evaluation, Novel Biomarker Development and Early Phase Clinical Trials of New Drugs.
2015
Research Grant
Discovery of New Treatments for Therapy-Resistant Multiple Myeloma.